About Us
BPCO Media began as a spin-off from Campus Bio-Medico University of Rome following a research project and is based on telemedicine and medical diagnostics research.
The primary therapeutic area that the multidisciplinary team has focused on is chronic obstructive pulmonary disease (COPD).
BPCO Media has developed an innovative device that is easy for patients with COPD to use. By monitoring parameters such as oxygen saturation in blood and heart rate, it can PREDICT AND MANAGE exacerbations of the disease.
Patients are not always able to perceive symptoms in time which can lead to a exacerbation and often to a hospital admission; using an algorithm based on artificial intelligence, the device PREDICTS and MANAGES the disease INTELLIGENTLY.
Management means acting preventively and in time, also with the support of the patient’s doctor, and avoiding a exacerbation and possible hospital admission.
Collaboration
Research and Development
Campus Bio-Medico University Hospital, Rome
Predictive Algorithm Validation, consultancy and clinical support for research, validations, clinical support for the development of new functionalities (walking test, respiratory rate, spirometry) for the application and extension of the algorithm to new diseases (ASTHMA, heart failure).
Department of Bioengineering, Campus Bio-Medico University of Rome
Development of the AI predictive algorithm on development and extension to new diseases.
AIPO study group
Support and participation in research, validation, development of new functionalities (walking test, respiratory rate, spirometry) for the application and extension of the algorithm to new diseases (ASTHMA, heart failure), clinical and real-life trials.
Technology
Ynnova srl – Padua
Development of Apps, the Cloud, experts in IoT
Department of Bioengineering, Campus Bio-Medico University of Rome
Development of DLL for Android and iOS apps.
Jumper Medical Co Ltd of Shenzhen (China)
Production of pulse oximetry and BPCO Media kits (App, Card, Packaging, Instructions)